16 employees
Spyglass Pharma provides medicine for ophthalmic diseases.
2019
$90M
from 4 investors over 4 rounds
SpyGlass Pharma, Inc. raised $90M on July 10, 2023
Investors: Vensana Capital, Vertex Ventures HC, Samsara BioCapital and RA Capital Management, L.P.